CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Ceribell, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$26.00+0.96 (+3.83%)
Close on Oct 19, 2026
- Market cap
- $988.83M
- P/E (TTM)
- –
- Dividend yield
- –
Ceribell, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | $77.24M | $71.92M | $67.34M | $62.70M | $59.00M | $54.65M | $50.08M | $45.94M | $41.38M | $34.57M | 75.7% | +30.9% |
| Subscription revenue | $24.73M | $23.15M | $21.73M | $20.12M | $18.42M | $16.88M | $15.37M | $14.10M | $13.08M | $10.66M | 24.3% | +34.3% |
By region
From the segment and revenue-disaggregation notes of Ceribell's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.